A detailed history of Cetera Investment Advisers transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 5,949 shares of AXSM stock, worth $517,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,949
Previous 6,132 2.98%
Holding current value
$517,265
Previous $493,000 8.32%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$78.93 - $95.84 $14,444 - $17,538
-183 Reduced 2.98%
5,949 $534,000
Q2 2024

Aug 22, 2024

BUY
$65.72 - $80.5 $30,034 - $36,788
457 Added 8.05%
6,132 $493,000
Q1 2024

May 24, 2024

BUY
$69.39 - $97.64 $393,788 - $554,107
5,675 New
5,675 $452,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.